Paul Knight
Stock Analyst at Keybanc
(1.86)
# 3,176
Out of 5,182 analysts
141
Total ratings
43.59%
Success rate
-3.09%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Overweight | $15 → $10 | $3.06 | +226.80% | 8 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $13.73 | +133.07% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $491.46 | +52.61% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $254.80 | +37.36% | 12 | Oct 24, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $3.84 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $126.01 | +74.59% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.77 | +71.04% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $5.20 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $53.13 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $304.24 | +51.20% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $0.91 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.27 | +252.42% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $88.94 | +63.03% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $155.72 | +169.71% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $98.31 | +133.95% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $19.51 | +69.14% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $24.84 | +44.93% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $191.12 | +62.20% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $117.78 | +86.79% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.95 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.16 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $115.48 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $22.63 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $7.90 | +406.33% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $173.89 | +72.52% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $173.26 | +44.29% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $117.81 | +274.33% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $123.31 | +91.39% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $70.17 | +41.09% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.95 | +294.27% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $32.25 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $91.08 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $127.38 | - | 5 | Oct 23, 2017 |
Exagen
Mar 11, 2026
Maintains: Overweight
Price Target: $15 → $10
Current: $3.06
Upside: +226.80%
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $13.73
Upside: +133.07%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $491.46
Upside: +52.61%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $254.80
Upside: +37.36%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $3.84
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $126.01
Upside: +74.59%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.77
Upside: +71.04%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $5.20
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $53.13
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $304.24
Upside: +51.20%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.91
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.27
Upside: +252.42%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $88.94
Upside: +63.03%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $155.72
Upside: +169.71%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $98.31
Upside: +133.95%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $19.51
Upside: +69.14%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $24.84
Upside: +44.93%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $191.12
Upside: +62.20%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $117.78
Upside: +86.79%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.95
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.16
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $115.48
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $22.63
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $7.90
Upside: +406.33%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $173.89
Upside: +72.52%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $173.26
Upside: +44.29%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $117.81
Upside: +274.33%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $123.31
Upside: +91.39%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $70.17
Upside: +41.09%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.95
Upside: +294.27%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $32.25
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $91.08
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $127.38
Upside: -